{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T01:48:47Z","timestamp":1768614527590,"version":"3.49.0"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,27]]},"DOI":"10.1515\/sjpain-2020-0178","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T17:05:01Z","timestamp":1615914301000},"page":"421-425","source":"Crossref","is-referenced-by-count":1,"title":["Some controversies related to questionable clinical uses of methadone for chronic non-cancer pain and in palliative care"],"prefix":"10.1515","volume":"21","author":[{"given":"Stephen H.","family":"Butler","sequence":"first","affiliation":[{"name":"Academic Hospital , Uppsala , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"2025120910014884126_j_sjpain-2020-0178_ref_001","doi-asserted-by":"crossref","unstructured":"Kharasch, ED. Intraoperative methadone: rediscovery, reappraisal, and reinvigoration. Anesth Analg 2011;12:13\u20136. https:\/\/doi.org\/10.1213\/ane.0b013e3181fec9a3.","DOI":"10.1213\/ANE.0b013e3181fec9a3"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_002","doi-asserted-by":"crossref","unstructured":"Melichar, JK, Hume, SP, Williams, TM, Daglish, Taylor, LG, Ahmed, R, et al.. Using [11C] diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies. J Pharmacol Exp Therapeut 2005;312:309\u201315. https:\/\/doi.org\/10.1124\/jpet.104.072686.","DOI":"10.1124\/jpet.104.072686"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_003","doi-asserted-by":"crossref","unstructured":"Lingford-Hughes, A. Human brain imaging and substance abuse. Curr Opin Pharmacol 2005;5:42\u20136. https:\/\/doi.org\/10.1016\/j.coph.2004.10.002.","DOI":"10.1016\/j.coph.2004.10.002"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_004","doi-asserted-by":"crossref","unstructured":"Hume, SP, Lingford-Hughes, AR, Hataf, V, Hirani, A, Ahmed, R, Davies, A, et al.. Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opioids. J Pharmacol Exp Therapeut 2007;322:661\u20137. https:\/\/doi.org\/10.1124\/jpet.107.121749.","DOI":"10.1124\/jpet.107.121749"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_005","doi-asserted-by":"crossref","unstructured":"Kling, MA, Carson, RE, Borg, L, Zametkin, A, Matochik, JA, Schluger, J, et al.. Opioid receptor imaging with positron emission tomography and [18F]cyclofoxy in long-term, methadone-treated former heroin addicts. J Pharmacol Exp Therapeut 2000;295:1070\u20136.","DOI":"10.1016\/S0022-3565(24)39007-X"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_006","doi-asserted-by":"crossref","unstructured":"Rodriguez-Martin, I, Braksator, E, Bailey, CP, Goodchild, S, Marrion, NV, Kelley, E, et al.. Methadone: does it really have low efficacy at u-opioid receptors? Neuroreport 2008;19:589\u201393. https:\/\/doi.org\/10.1097\/wnr.0b013e3282f97b64.","DOI":"10.1097\/WNR.0b013e3282f97b64"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_007","doi-asserted-by":"crossref","unstructured":"Volpe, DA, Tobun, GA, Mellon, RD, Katki, AG, Parker, RJ, Colarsky, T, et al.. Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol 2011;59:385\u201390. https:\/\/doi.org\/10.1016\/j.yrtph.2010.12.007.","DOI":"10.1016\/j.yrtph.2010.12.007"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_008","unstructured":"Halpern, L. Substitution-detoxification and its role in the management of chronic benign pain. J Clin Psychiatr 1982;43:10\u20134."},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_009","doi-asserted-by":"crossref","unstructured":"Melichar, JK, Myles, JS, Eap, CB, Nutt, DJ. Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test. Addiction Biol 2003;8:59\u201366. https:\/\/doi.org\/10.1080\/1355621031000069891.","DOI":"10.1080\/1355621031000069891"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_010","doi-asserted-by":"crossref","unstructured":"Donny, EC, Walsh, SL, Bigelow, GR, Eissenberg, T, Stitzer, ML. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid dependent humans. Psychopharmacology 2002;161:201\u201312. https:\/\/doi.org\/10.1007\/s00213-002-1027-0.","DOI":"10.1007\/s00213-002-1027-0"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_011","doi-asserted-by":"crossref","unstructured":"Jiang, H, Hillhouse, M, Du, J, Pan, S, Alfonso, A, Wang, J, et al.. Dose, plasma level, and treatment outcome among methadone patients in Shanghai, China. Neurosci Bull 2016;32:538\u201344. https:\/\/doi.org\/10.1007\/s12264-016-0059-0.","DOI":"10.1007\/s12264-016-0059-0"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_012","doi-asserted-by":"crossref","unstructured":"Eap, CB, Bertschy, G, Baumann, P, Finkbeiner, T, Gastbar, M, Schebaum, N. High interindividual variability of methadone enantiomer blood levels to dose ratios. Arch Gen Psychiatr 1998;55:88\u201390. https:\/\/doi.org\/10.1001\/archpsyc.55.1.89.","DOI":"10.1001\/archpsyc.55.1.89"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_013","doi-asserted-by":"crossref","unstructured":"Fonceca, F, Torrens, M. Psychogenetics of methadone response. Mol Diagn Ther 2018;22:57\u201378.","DOI":"10.1007\/s40291-017-0311-y"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_014","unstructured":"Leavitt, SB, Shinderman, M, Maxwell, E, Eap, CB, Paris, P. When \u201cenough\u201d is not enough: new perspectives on optimal methadone maintenance dose. Mt Sinai J Med 2000;67:404\u201311."},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_015","doi-asserted-by":"crossref","unstructured":"Mercadente, S. Opioid rotation in cancer pain. Rational and clinical aspects. Cancer 1999;86:1856\u201366.","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_016","doi-asserted-by":"crossref","unstructured":"Pasternak, GW. Incomplete cross-tolerance and multiple mu-opioid peptide receptors. Trends Pharmacol Sci 2001;22:67\u201370. https:\/\/doi.org\/10.1016\/s0165-6147(00)01616-3.","DOI":"10.1016\/S0165-6147(00)01616-3"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_017","doi-asserted-by":"crossref","unstructured":"Posa, L, Accarie, A, Noble, F, Marie, N. Methadone reverses analgesic tolerance induced by morphine pretreatment. Int J Neuropsychopharmacol 2016;19:1\u201311. https:\/\/doi.org\/10.1093\/ijnp\/pyv108.","DOI":"10.1093\/ijnp\/pyv108"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_018","doi-asserted-by":"crossref","unstructured":"Gorman, AL, Elliott, KJ, Inturrisi, E. The d- and l-isomers of methadone bind to the noncompetitive site on the N-methyl-D-aspartate (NMDA) receptor in the rat forebrain and spinal cord. Neurosci Lett 1997;223:5\u20138. https:\/\/doi.org\/10.1016\/s0304-3940(97)13391-2.","DOI":"10.1016\/S0304-3940(97)13391-2"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_019","doi-asserted-by":"crossref","unstructured":"Doi, S, Mori, T, Uzama, N, Arima, T, Takahashi, T, Uchida, M, et al.. Characterization of methadone as a \u03b2-arrestin-biased u-opioid receptor agonist. Mol Pain 2016;12:1\u20139. https:\/\/doi.org\/10.1177\/1744806916654146.","DOI":"10.1177\/1744806916654146"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_020","doi-asserted-by":"crossref","unstructured":"McNichol, ED, Ferguson, MC, Schumann, R. Methadone for neuropathic pain in adults. Cochrane Database Syst Rev 2017;5:CD0112499.","DOI":"10.1002\/14651858.CD012499"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_021","doi-asserted-by":"crossref","unstructured":"Brown, R, Kraus, C, Fleming, M, Reddy, S. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med 2004;80:654\u201359. https:\/\/doi.org\/10.1136\/pgmj.2004.022988.","DOI":"10.1136\/pgmj.2004.022988"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_022","doi-asserted-by":"crossref","unstructured":"Hayes, CL, Krebs, EE, Hudson, Y, Brown, J, Li, C, Martin, B. Impact of opioid dose escalation on pain intensity: a retrospective study. Pain 2020;161:979\u201388. https:\/\/doi.org\/10.1097\/j.pain.0000000000001784.","DOI":"10.1097\/j.pain.0000000000001784"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_023","doi-asserted-by":"crossref","unstructured":"Chou, R, Cruciani, RA, Fiellin, DA, Compton, P, Farrar, JT, Haigney, MC, et al.. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence in collaboration with the Heart Rhythm Society. J Pain 2014;15:321\u201334. https:\/\/doi.org\/10.1016\/j.jpain.2014.01.494.","DOI":"10.1016\/j.jpain.2014.01.494"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_024","doi-asserted-by":"crossref","unstructured":"Benyamin, R, Trescot, AM, Datta, S, Buenevantura, R, Adlaki, R, Sehgal, N, et al.. Opioid complications and side effects. Pain Physician 2008;11:S105\u201320.","DOI":"10.36076\/ppj.2008\/11\/S105"},{"key":"2025120910014884126_j_sjpain-2020-0178_ref_025","doi-asserted-by":"crossref","unstructured":"Weinfurt, K. Vanquishing false idols, then and now. Science 2020;367:1312. https:\/\/doi.org\/10.1126\/science.aba5802.","DOI":"10.1126\/science.aba5802"}],"container-title":["Scandinavian Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2020-0178\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2020-0178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:28:30Z","timestamp":1765283310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2020-0178\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,4,12]]},"published-print":{"date-parts":[[2021,7,27]]}},"alternative-id":["10.1515\/sjpain-2020-0178"],"URL":"https:\/\/doi.org\/10.1515\/sjpain-2020-0178","relation":{},"ISSN":["1877-8860","1877-8879"],"issn-type":[{"value":"1877-8860","type":"print"},{"value":"1877-8879","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]}}}